Crucell N.V.

Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.

Publicatie datum 14 jan 2008 - 14:01

Statutaire naam Crucell N.V.

Titel Crucell Announces STAR® Technology Research License with Korean-based ISU ABXIS

Bericht Leiden, The Netherlands, 14 January 2007 - Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL, Swiss Exchange: CRX) today announced a non-exclusive STAR® research license agreement with Korean-based ISU ABXIS. The license covers both a research evaluation of STAR® technology for the production of recombinant proteins and an option for a commercial license. Financial details of the agreement were not disclosed.

Vorige register resultaat

Volgende register resultaat

Gerelateerde downloads

200801140000000018_ISU_STAR_PR_FINAL_14jan2008.pdf (opens in a new window)

Datum laatste update: 19 december 2025